The Baldwin Insurance Group, Inc.

NasdaqGS:BWIN Stock Report

Market Cap: US$5.2b

Baldwin Insurance Group Valuation

Is BWIN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BWIN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BWIN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BWIN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BWIN?

Key metric: As BWIN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BWIN. This is calculated by dividing BWIN's market cap by their current revenue.
What is BWIN's PS Ratio?
PS Ratio2.3x
SalesUS$1.34b
Market CapUS$5.20b

Price to Sales Ratio vs Peers

How does BWIN's PS Ratio compare to its peers?

The above table shows the PS ratio for BWIN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.4x
GSHD Goosehead Insurance
10.4x24.0%US$4.5b
HGTY Hagerty
0.9x13.5%US$3.8b
RYAN Ryan Specialty Holdings
3.8x18.0%US$18.4b
TWFG TWFG
2.5x18.4%US$1.8b
BWIN Baldwin Insurance Group
2.3x12.9%US$5.2b

Price-To-Sales vs Peers: BWIN is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (4.4x).

Price to Sales Ratio vs Industry

How does BWIN's PS Ratio compare vs other companies in the US Insurance Industry?

9 CompaniesPrice / SalesEstimated GrowthMarket Cap
GOCO GoHealth
0.2x8.0%US$257.46m
CCG Cheche Group
0.2x5.6%US$66.33m
AAME Atlantic American
0.2xn/aUS$32.64m
CNFR Conifer Holdings
0.2xn/aUS$14.55m
BWIN 2.3xIndustry Avg. 1.1xNo. of Companies22PS00.81.62.43.24+
9 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BWIN is expensive based on its Price-To-Sales Ratio (2.3x) compared to the US Insurance industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is BWIN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BWIN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: BWIN is expensive based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BWIN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$45.47
US$51.00
+12.2%
13.0%US$60.00US$43.00n/a7
Nov ’25US$45.29
US$54.00
+19.2%
10.5%US$60.00US$46.00n/a7
Oct ’25US$49.10
US$45.29
-7.8%
10.3%US$50.00US$38.00n/a7
Sep ’25US$46.89
US$45.29
-3.4%
10.3%US$50.00US$38.00n/a7
Aug ’25US$43.21
US$40.29
-6.8%
10.8%US$46.00US$34.00n/a7
Jul ’25US$36.29
US$36.86
+1.6%
16.4%US$45.00US$28.00n/a7
Jun ’25US$33.68
US$36.00
+6.9%
16.5%US$45.00US$28.00n/a7
May ’25US$27.45
US$34.71
+26.5%
15.2%US$44.00US$28.00n/a7
Apr ’25US$28.55
US$33.00
+15.6%
16.9%US$42.00US$27.00n/a7
Mar ’25US$27.94
US$31.43
+12.5%
15.3%US$42.00US$27.00n/a7
Feb ’25US$22.70
US$30.14
+32.8%
21.0%US$44.00US$24.00n/a7
Jan ’25US$24.02
US$29.86
+24.3%
17.7%US$41.00US$24.00n/a7
Dec ’24US$17.60
US$29.86
+69.6%
17.7%US$41.00US$24.00n/a7
Nov ’24US$20.98
US$31.00
+47.8%
14.6%US$41.00US$27.00US$45.297
Oct ’24US$23.23
US$31.86
+37.1%
14.6%US$41.00US$27.00US$49.107
Sep ’24US$27.00
US$31.86
+18.0%
14.6%US$41.00US$27.00US$46.897
Aug ’24US$25.18
US$31.71
+26.0%
13.6%US$38.00US$26.00US$43.217
Jul ’24US$24.78
US$33.00
+33.2%
10.7%US$38.00US$27.00US$36.297
Jun ’24US$20.63
US$33.00
+60.0%
10.7%US$38.00US$27.00US$33.687
May ’24US$25.20
US$33.57
+33.2%
9.3%US$38.00US$28.00US$27.457
Apr ’24US$25.46
US$34.14
+34.1%
7.9%US$37.00US$29.00US$28.557
Mar ’24US$27.59
US$34.57
+25.3%
8.3%US$37.00US$29.00US$27.947
Feb ’24US$29.77
US$34.43
+15.6%
9.9%US$38.00US$28.00US$22.707
Jan ’24US$25.14
US$32.86
+30.7%
9.4%US$37.00US$28.00US$24.027
Dec ’23US$30.61
US$32.88
+7.4%
8.8%US$37.00US$28.00US$17.608
Nov ’23US$28.64
US$33.38
+16.5%
8.7%US$37.00US$29.00US$20.988

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Fidelis Insurance Holdings

US$2.2b

A specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom.

FIHL

US$19.90

7D

-0.2%

1Y

62.1%

Markel Group

US$21.5b

A diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany.

MKL

US$1,694.12

7D

2.3%

1Y

18.5%

China Life Insurance

HK$1.1t

Operates as a life insurance company in the People’s Republic of China.

CILJ.F

HK$2.00

7D

-0.6%

1Y

46.0%